Waldencast (NASDAQ:WALDW – Get Free Report) and Kenvue (NYSE:KVUE – Get Free Report) are both consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership.
Institutional & Insider Ownership
97.6% of Kenvue shares are owned by institutional investors. 1.6% of Kenvue shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Waldencast and Kenvue”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Waldencast | $272.07 million | N/A | N/A | N/A | N/A |
| Kenvue | $15.41 billion | 2.40 | $1.47 billion | $0.87 | 22.10 |
Kenvue has higher revenue and earnings than Waldencast.
Profitability
This table compares Waldencast and Kenvue’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Waldencast | N/A | N/A | N/A |
| Kenvue | 10.76% | 21.22% | 8.37% |
Analyst Recommendations
This is a breakdown of current ratings and price targets for Waldencast and Kenvue, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Waldencast | 0 | 0 | 0 | 0 | 0.00 |
| Kenvue | 0 | 12 | 3 | 0 | 2.20 |
Kenvue has a consensus price target of $19.27, indicating a potential upside of 0.22%. Given Kenvue’s stronger consensus rating and higher possible upside, analysts plainly believe Kenvue is more favorable than Waldencast.
Summary
Kenvue beats Waldencast on 9 of the 9 factors compared between the two stocks.
About Waldencast
Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.
About Kenvue
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
